This site uses cookies to improve your browsing experience. By using this site, you agree to their use. Cookie Information

ESMO-WCGC Barcelona, Spain 3-6 July 2019

NRG1 fusion-positive gastrointestinal tumours: Afatinib as a novel potential treatment option

Benjamin A. Weinberg, Daniel Renouf, Howard Lim, Christoph Heining, Richard F. Schlenk, Martin R. Jones, Stephen V. Liu, Agnieszka Cseh, Flavio Solca, Janessa J. Laskin

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

FOR HEALTHCARE PROFESSIONALS ONLY.

image